Monocyte-to-macrophage differentiation, which can be initiated by physiological or atherogenic factors, is a pivotal process in atherogenesis, a disorder in which monocytes adhere to endothelial cells and subsequently migrate into the subendothelial spaces, where they differentiate into macrophages and macrophage-derived foam cells and cause atherosclerotic lesions. However, the monocyte-differentiation signaling pathways that are activated by atherogenic factors are poorly defined. Here we report that the AMP-activated protein kinase α1 (AMPKα1) in monocytes promotes atherosclerosis by increasing monocyte differentiation and survival. Exposure of monocytes to oxidized low-density lipoprotein, 7-ketocholesterol, phorbol 12-myristate 13-acetate, or macrophage colony-stimulated factor (M-CSF) significantly activated AMPK and promoted monocyte-to-macrophage differentiation. M-CSF-activated AMPK is via M-CSF receptor-dependent reactive oxygen species production. Consistently, genetic deletion of AMPKα1 or pharmacological inhibition of AMPK blunted monocyte-to-macrophage differentiation and promoted monocyte/macrophage apoptosis. Compared with apolipoprotein E knock-out (ApoE−/−) mice, which show impaired clearing of plasma lipoproteins and spontaneously develop atherosclerosis, ApoE−/−/AMPKα1−/− mice showed reduced sizes of atherosclerotic lesions and lesser numbers of macrophages in the lesions. Furthermore, aortic lesions were decreased in ApoE−/− mice transplanted with ApoE−/−/AMPKα1−/− bone marrow and in myeloid-specific AMPKα1-deficient ApoE−/− mice. Finally, rapamycin treatment, which abolished delayed monocyte differentiation in ApoE−/−/AMPKα1−/− mice, lost its atherosclerosis-lowering effects in these mice. Mechanistically, we found that AMPKα1 regulates FoxO3-dependent expression of both LC3 and ULK1, which are two important autophagy-related markers. Rapamycin treatment increased FoxO3 activity as well as LC3 and ULK1 expressions in macrophages from AMPKα1−/− mice. Our results reveal that AMPKα1 deficiency impairs autophagy-mediated monocyte differentiation and decreases monocyte/macrophage survival, which attenuates atherosclerosis in ApoE−/− mice in vivo.
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2r6VkKH
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
2016-10-16T06-25-49Z Source: Indo American Journal of Pharmaceutical Research Maha A. Sultan, Maha M. Abou El-Alamin, Mostafa A. Atia*, H...
-
Abstract Psoriatic arthritis (PsA) is a form of inflammatory arthritis (IA) affecting approximately 0.25% of the population. It is a hetero...
-
Abstract The objective of this study was to explore the factors that influence perceived personal risk of developing breast cancer (BC) in...
-
2016-11-19T05-04-49Z Source: International Journal of Basic & Clinical Pharmacology Monica N., Jayanthi CR, Praveen Panchaksharimath....
-
Abstract The problems with China’s regional industrial overcapacity are often influenced by local governments. This study constructs a fram...
-
Objectives A major measure of treatment success for drug users undergoing rehabilitation is the ability to enter the workforce and generate ...
-
Related Articles [Sarcomatoid carcinoma of larynx. A histological challenge?] Rev Esp Patol. 2018 Jan - Mar;51(1):30-33 Authors: Oso...
-
Abstract Chickens are considered important in the epidemiology of Toxoplasma gondii . Chicken hearts ( n = 1185) obtained from grocery st...
-
by Ahmed Elhady, Ariadna Giné, Olivera Topalovic, Samuel Jacquiod, Søren J. Sørensen, Francisco Javier Sorribas, Holger Heuer Endoparasitic...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου